Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38627442)

  • 1. New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses.
    Karaca C; Demir Karaman E; Leblebici A; Kurter H; Ellidokuz H; Koc A; Ellidokuz EB; Isik Z; Basbinar Y
    Sci Rep; 2024 Apr; 14(1):8762. PubMed ID: 38627442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
    Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
    Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of FZXJJZ decoction suppresses colorectal liver metastasis via the VDR/TGF-β/Snail1 signaling pathways based on network pharmacology-TCGA data-transcriptomics analysis.
    Li Q; Chen JX; Wu Y; Lv LL; Ying HF; Zhu WH; Xu JY; Ruan M; Guo Y; Zhu WR; Zheng L
    J Ethnopharmacol; 2022 Apr; 287():114904. PubMed ID: 34952191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway.
    Li LX; Lam IH; Liang FF; Yi SP; Ye LF; Wang JT; Guo WW; Xu M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1487-1493. PubMed ID: 30840270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
    Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
    Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Gao B; Shao Q; Choudhry H; Marcus V; Dong K; Ragoussis J; Gao ZH
    Int J Oncol; 2016 Sep; 49(3):1108-18. PubMed ID: 27571956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
    Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
    BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl-hydrocarbon receptor-interacting protein regulates tumorigenic and metastatic properties of colorectal cancer cells driving liver metastasis.
    Solís-Fernández G; Montero-Calle A; Sánchez-Martínez M; Peláez-García A; Fernández-Aceñero MJ; Pallarés P; Alonso-Navarro M; Mendiola M; Hendrix J; Hardisson D; Bartolomé RA; Hofkens J; Rocha S; Barderas R
    Br J Cancer; 2022 Jun; 126(11):1604-1615. PubMed ID: 35347323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2.
    Ni L; Sun P; Ai M; Kong L; Xu R; Li J
    Phytomedicine; 2022 Sep; 104():154303. PubMed ID: 35802997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
    Lu H; Yao B; Wen X; Jia B
    BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
    Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
    Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.
    Macha MA; Rachagani S; Gupta S; Pai P; Ponnusamy MP; Batra SK; Jain M
    Cancer Lett; 2013 Dec; 341(2):166-77. PubMed ID: 23920124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.